JPWO2022158591A1 - - Google Patents

Info

Publication number
JPWO2022158591A1
JPWO2022158591A1 JP2022576771A JP2022576771A JPWO2022158591A1 JP WO2022158591 A1 JPWO2022158591 A1 JP WO2022158591A1 JP 2022576771 A JP2022576771 A JP 2022576771A JP 2022576771 A JP2022576771 A JP 2022576771A JP WO2022158591 A1 JPWO2022158591 A1 JP WO2022158591A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022576771A
Other languages
Japanese (ja)
Other versions
JPWO2022158591A5 (enExample
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2022158591A1 publication Critical patent/JPWO2022158591A1/ja
Publication of JPWO2022158591A5 publication Critical patent/JPWO2022158591A5/ja
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/26Iron; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2022576771A 2021-01-25 2022-01-24 Pending JPWO2022158591A1 (enExample)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2021009754 2021-01-25
PCT/JP2022/002413 WO2022158591A1 (ja) 2021-01-25 2022-01-24 肥大型心筋症治療剤

Publications (2)

Publication Number Publication Date
JPWO2022158591A1 true JPWO2022158591A1 (enExample) 2022-07-28
JPWO2022158591A5 JPWO2022158591A5 (enExample) 2025-01-22

Family

ID=82548732

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022576771A Pending JPWO2022158591A1 (enExample) 2021-01-25 2022-01-24

Country Status (5)

Country Link
US (1) US20240082189A1 (enExample)
EP (1) EP4309651A4 (enExample)
JP (1) JPWO2022158591A1 (enExample)
CN (1) CN116829138A (enExample)
WO (1) WO2022158591A1 (enExample)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA06012636A (es) 2004-04-28 2007-03-21 Yoshiyasu Ito Regenerador de cabello.
JP5098051B2 (ja) * 2007-04-05 2012-12-12 Sbiファーマ株式会社 ミトコンドリア障害脳疾患治療剤及び診断剤
JP5611548B2 (ja) * 2009-07-08 2014-10-22 Sbiファーマ株式会社 5−アミノレブリン酸若しくはその誘導体、又はそれらの塩を有効成分とするがんの予防・改善剤
JP7430916B2 (ja) * 2018-09-20 2024-02-14 国立大学法人北海道大学 心不全の病態の評価のための方法、バイオマーカー、候補化合物の評価方法、医薬用組成物及び心不全の治療剤
US20240173283A1 (en) * 2021-03-23 2024-05-30 Kyushu University, National University Corporation Prophylactic agent or therapeutic agent for side effects of anthracycline anticancer agent

Also Published As

Publication number Publication date
US20240082189A1 (en) 2024-03-14
WO2022158591A1 (ja) 2022-07-28
EP4309651A1 (en) 2024-01-24
EP4309651A4 (en) 2024-11-06
CN116829138A (zh) 2023-09-29

Similar Documents

Publication Publication Date Title
BR112023012656A2 (enExample)
BR112021014123A2 (enExample)
BR112023009656A2 (enExample)
BR112022009896A2 (enExample)
BR112023008622A2 (enExample)
BR112022024743A2 (enExample)
BR112023011738A2 (enExample)
BR112023006729A2 (enExample)
BR102021018859A2 (enExample)
BR102021015500A2 (enExample)
BR112021017747A2 (enExample)
BR112023016292A2 (enExample)
JPWO2022158591A1 (enExample)
BR112023011539A2 (enExample)
BR112023011610A2 (enExample)
BR112023008976A2 (enExample)
BR102021020147A2 (enExample)
BR102021018926A2 (enExample)
BR102021018167A2 (enExample)
BR102021017576A2 (enExample)
BR102021016837A2 (enExample)
BR102021016551A2 (enExample)
BR102021016375A2 (enExample)
BR102021016200A2 (enExample)
BR102021016176A2 (enExample)

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250114

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250114